-
PurposeExpresses HSV-TK and Luciferase in an NRF2 dependent manner. Also, expresses cherry and blasticidin resistance selection markers
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 161789 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepLenti-Luc-2A-Ctx
-
Backbone manufacturerSystems Biosciences
- Backbone size w/o insert (bp) 8000
- Total vector size (bp) 10962
-
Modifications to backboneAdded ARE (Murine gclc promoter sequnce) to make Luc-2A-Ctx NRF2 dependent and mCherry/Blasticidin for selection
-
Vector typeMammalian Expression, Lentiviral, Luciferase
-
Selectable markersBlasticidin ; mCherry
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberLow Copy
Gene/Insert 1
-
Gene/Insert nameLuciferase-T2A-HSV-TK
-
SpeciesSynthetic
-
GenBank IDN/A
- Promoter Murine Gclc ARE
Cloning Information for Gene/Insert 1
- Cloning method Gibson Cloning
- 5′ sequencing primer N/A
- 3′ sequencing primer N/A (Common Sequencing Primers)
Gene/Insert 2
-
Gene/Insert namemCherry P2A blasticidin
-
SpeciesSynthetic
-
GenBank IDN/A
- Promoter EF1a
Cloning Information for Gene/Insert 2
- Cloning method Gibson Cloning
- 5′ sequencing primer N/A
- 3′ sequencing primer N/A (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
Addgene Notes
-
A portion of this plasmid was derived from a plasmid made bySystems Biosciences
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Plenti-ARE-HSVTK-luc was a gift from Hans-Guido Wendel (Addgene plasmid # 161789) -
For your References section:
The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase. Sanghvi VR, Leibold J, Mina M, Mohan P, Berishaj M, Li Z, Miele MM, Lailler N, Zhao C, de Stanchina E, Viale A, Akkari L, Lowe SW, Ciriello G, Hendrickson RC, Wendel HG. Cell. 2019 Aug 8;178(4):807-819.e21. doi: 10.1016/j.cell.2019.07.031. 10.1016/j.cell.2019.07.031 PubMed 31398338